Imunon, Inc.
IMNN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15,103 | $17,626 | $17,579 | $15,842 |
| - Cash | $0 | $4,729 | $2,872 | $5,873 |
| + Debt | $1,102,232 | $1,193 | $1,008 | $1,139 |
| Enterprise Value | $1,117,335 | $14,090 | $15,715 | $11,109 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$167 | -$165 | -$2,165 | -$165 |
| % Margin | – | – | – | – |
| EBITDA | -$3,262 | -$2,576 | -$4,079 | -$3,892 |
| % Margin | – | – | – | – |
| Net Income | -$3,429 | -$2,741 | -$4,102 | -$4,057 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.16 | -1.87 | -3.676 | -3.65 |
| % Growth | 38% | 49.1% | -0.7% | – |
| Operating Cash Flow | -$4,441 | -$2,951 | -$2,847 | -$4,421 |
| Capital Expenditures | $0 | -$17 | -$260 | -$15 |
| Free Cash Flow | -$4,441 | -$2,969 | -$3,107 | -$4,436 |